Clostridioides difficile (C. difficile) is the leading cause of hospital acquired diarrhoeal
infection. The major risk factors associated with C. difficile infection (CDI) is age (65 and …

Clostridioides difficile is the main cause of health-care-associated infectious diarrhoea.
Toxins, TcdA and TcdB, secreted by this bacterium damage colonic epithelial cells and in …

Clostridioides difficile infection (CDI) presents a major public health threat by causing
frequently recurrent, life-threatening cases of diarrhea and intestinal inflammation. The …

Clostridium difficile associated disease is fundamentally associated with dysbiosis of the gut
microbiome as a consequence of antibiotic use. This is because this sporulating, obligate …

Clostridioides difficile is an opportunistic gut pathogen which causes severe colitis, leading
to significant morbidity and mortality due to its toxins, TcdA and TcdB. Two intra-muscular …

Clostridium difficile diarrhoea and colitis is a new disease that is attributable to broad
spectrum antibiotic therapy. During the past 2 decades C. difficile has become one of the …

Clostridioides difficile (CD) is a Gram-positive, anaerobic bacterium that infects mainly
hospitalized and elderly people who have been treated with long-term antibiotic therapy …

Clostridioides difficile infection (CDI) is one of the most important nosocomial infections in
the world. In 2012, approximately 40,000 CDI cases were reported in Canada with a cost of …

Clostridium difficile, a gram-positive bacterium, is the major cause of hospital-acquired
infectious diarrhea and colitis in industrialized nations. C. difficile colonization results from …

Background In the absence of a licensed vaccine, Clostridioides (formerly Clostridium)
difficile infection represents a substantial health burden. The aim of this study was to …